scholarly journals Depletion of dAKAP1–protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility

2018 ◽  
Vol 294 (9) ◽  
pp. 3152-3168 ◽  
Author(s):  
Stacey Aggarwal ◽  
Laura Gabrovsek ◽  
Lorene K. Langeberg ◽  
Martin Golkowski ◽  
Shao-En Ong ◽  
...  
2005 ◽  
Vol 16 (7) ◽  
pp. 3117-3127 ◽  
Author(s):  
Rosa A. Cardone ◽  
Anna Bagorda ◽  
Antonia Bellizzi ◽  
Giovanni Busco ◽  
Lorenzo Guerra ◽  
...  

Metastasis results from a sequence of selective events often involving interactions with elements of the tumor-specific physiological microenvironment. The low-serum component of this microenvironment confers increased motility and invasion in breast cancer cells by activating the Na+/H+ exchanger isoform 1 (NHE1). The present study was undertaken to characterize the signal transduction mechanisms underlying this serum deprivation-dependent activation of both the NHE1 and the concomitant invasive characteristics such as leading edge pseudopodia development and penetration of matrigel in breast cancer cell lines representing different stages of metastatic progression. Using pharmacological and genetic manipulation together with transport and kinase activity assays, we observe that the activation of the NHE1 and subsequent invasion by serum deprivation in metastatic human breast cells is coordinated by a sequential RhoA/p160ROCK/p38MAPK signaling pathway gated by direct protein kinase A phosphorylation and inhibition of RhoA. Fluorescence resonance energy transfer imaging of RhoA activity and immunofluorescence analysis of phospho-RhoA and NHE1 show that serum deprivation dynamically remodels the cell, forming long, leading edge pseudopodia and that this signal module is preferentially compartmentalized in these leading edge pseudopodia, suggesting a tight topographic relation of the signaling module to an invasion-specific cell structure.


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Emma J. Mah ◽  
Austin E. Y. T. Lefebvre ◽  
Gabrielle E. McGahey ◽  
Albert F. Yee ◽  
Michelle A. Digman

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Rotem Katzir ◽  
Ibrahim H. Polat ◽  
Michal Harel ◽  
Shir Katz ◽  
Carles Foguet ◽  
...  

AbstractAltered metabolism is a hallmark of cancer, but little is still known about its regulation. In this study, we measure transcriptomic, proteomic, phospho-proteomic and fluxomics data in a breast cancer cell-line (MCF7) across three different growth conditions. Integrating these multiomics data within a genome scale human metabolic model in combination with machine learning, we systematically chart the different layers of metabolic regulation in breast cancer cells, predicting which enzymes and pathways are regulated at which level. We distinguish between two types of reactions, directly and indirectly regulated. Directly-regulated reactions include those whose flux is regulated by transcriptomic alterations (~890) or via proteomic or phospho-proteomics alterations (~140) in the enzymes catalyzing them. We term the reactions that currently lack evidence for direct regulation as (putative) indirectly regulated (~930). Many metabolic pathways are predicted to be regulated at different levels, and those may change at different media conditions. Remarkably, we find that the flux of predicted indirectly regulated reactions is strongly coupled to the flux of the predicted directly regulated ones, uncovering a tiered hierarchical organization of breast cancer cell metabolism. Furthermore, the predicted indirectly regulated reactions are predominantly reversible. Taken together, this architecture may facilitate rapid and efficient metabolic reprogramming in response to the varying environmental conditions incurred by the tumor cells. The approach presented lays a conceptual and computational basis for mapping metabolic regulation in additional cancers.


2016 ◽  
Vol 10 (8) ◽  
pp. 1026-1033 ◽  
Author(s):  
Amy T. Shah ◽  
Taylor M. Cannon ◽  
James N. Higginbotham ◽  
Robert J. Coffey ◽  
Melissa C. Skala

2014 ◽  
Vol 54 (9) ◽  
pp. 810-820 ◽  
Author(s):  
Michael Mouradian ◽  
Keith D. Kikawa ◽  
Brian P. Dranka ◽  
Steven M. Komas ◽  
Balaraman Kalyanaraman ◽  
...  

2016 ◽  
Vol 23 (5) ◽  
pp. 567-578 ◽  
Author(s):  
Sharon M. Louie ◽  
Elizabeth A. Grossman ◽  
Lisa A. Crawford ◽  
Lucky Ding ◽  
Roman Camarda ◽  
...  

2016 ◽  
Vol 213 (2) ◽  
pp. 163-171 ◽  
Author(s):  
Kenneth R. Pryde ◽  
Heather L. Smith ◽  
Kai-Yin Chau ◽  
Anthony H.V. Schapira

Mitochondrial fission is essential for the degradation of damaged mitochondria. It is currently unknown how the dynamin-related protein 1 (DRP1)–associated fission machinery is selectively targeted to segregate damaged mitochondria. We show that PTEN-induced putative kinase (PINK1) serves as a pro-fission signal, independently of Parkin. Normally, the scaffold protein AKAP1 recruits protein kinase A (PKA) to the outer mitochondrial membrane to phospho-inhibit DRP1. We reveal that after damage, PINK1 triggers PKA displacement from A-kinase anchoring protein 1. By ejecting PKA, PINK1 ensures the requisite fission of damaged mitochondria for organelle degradation. We propose that PINK1 functions as a master mitophagy regulator by activating Parkin and DRP1 in response to damage. We confirm that PINK1 mutations causing Parkinson disease interfere with the orchestration of selective fission and mitophagy by PINK1.


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Illa Tea ◽  
Estelle Martineau ◽  
Ingrid Antheaume ◽  
Julie Lalande ◽  
Caroline Mauve ◽  
...  

2020 ◽  
Author(s):  
Ashley V. Ward ◽  
Shawna B. Matthews ◽  
Lynsey M. Fettig ◽  
Jessica Finlay-Schultz ◽  
Peter Kabos ◽  
...  

Abstract Progesterone receptors (PR) profoundly influence breast cancer biology by modifying estrogen receptor (ER) gene regulation, and, under some contexts, increasing populations of cancer stem cells. Abnormal metabolism is a cancer hallmark that has largely been understudied in relation to hormones in ER+PR+ breast disease. In this study, we investigated how progestins, in the absence or presence of estrogens, affect breast cancer cell metabolism. We measured metabolites using ultra-performance liquid chromatography coupled with mass spectrometry (UPLC-MS) in three ER+PR+ breast cancer cell lines (T47D, UCD4, and UCD65) treated with vehicle, estrogen only, progestin only, or the combination. Progestins, in the absence or presence of estrogens, largely downregulated metabolites, particularly those involved in tricarboxylic acid (TCA) cycle and amino acid metabolism. Seahorse metabolic analysis found progestins (alone or plus estrogens) generally shifted cells towards glycolysis with reduced ATP production. Transmission electron microscopy in cell lines and patient-derived xenograft tumors found that estrogens produced an elongated mitochondrial morphology, while estrogen plus progestin treatment reversed this trend. Using the photoconvertible MitoTimer reporter, progestins reduced both baseline and estrogen-induced mitochondrial turnover. Progestins blocked the estrogen-induced expression of mitochondrial biogenesis regulators PGC1α and PGC1β and their downstream targets. These findings indicate that progestins dominantly affect cell metabolism to shift cells to a more glycolytic phenotype with reduced mitochondrial function and amino acid pools; this transition is indicative of less proliferative, but also more dedifferentiated cells. Our results highlight potential benefits and detriments of current clinical studies testing selective PR modulators in ER+ breast cancers.


Sign in / Sign up

Export Citation Format

Share Document